{
  "docId": "019de073-9cbe-768d-a7d1-8fc0965b655d",
  "docSlug": "4ccbe5a4f667a79f6253d55ec8458249",
  "documentTitle": "Absci | Investor Presentation Deck | 26 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 26,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "Uses a simple Venn-like diagram to illustrate the small subset of successful drugs.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9cbe-768d-a7d1-8fc0965b655d/7",
  "deckHref": "/decks/019de073-9cbe-768d-a7d1-8fc0965b655d",
  "deckJsonHref": "/decks/019de073-9cbe-768d-a7d1-8fc0965b655d.json",
  "deckAnchorHref": "/decks/019de073-9cbe-768d-a7d1-8fc0965b655d#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.23,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Conventional drug discovery candidates",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "479ad3fa-526d-49b0-adca-19b598f904da",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.25,
        "x": 0.59,
        "y": 0.47
      },
      "kind": "callout",
      "text": "Only 4%* of drugs that make it from discovery to commercial launch",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe8e33db-e5e9-4d42-85e1-58e7df8ba5e4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.37,
        "y": 0.46
      },
      "kind": "diagram",
      "text": null,
      "attrs": null,
      "subkind": "venn",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1bd1212-5db6-4643-99e8-25c30b416766",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.035,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "*Paul, S., Mytelka, D., Dunwiddie, C. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 9, 203–214 (2010).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea8feafc-7729-4a7e-9db1-a21e647e55a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.035,
        "y": 0.115
      },
      "kind": "title",
      "text": "Biologic drug discovery fails too often",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc8aa1c8-4afa-4ae7-9619-252512303e22",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.1,
        "x": 0.035,
        "y": 0.065
      },
      "kind": "title",
      "text": "The Problem",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "359073a4-d2e9-4b77-ae5a-167f9feefb11",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Authority citation",
      "slug": "authority-citation",
      "agent": null,
      "layer": "slide",
      "matchId": "43e0416f-eaf2-40a8-9261-7c9c95f72d41",
      "evidence": "*Paul, S., Mytelka, D., Dunwiddie, C. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov 9, 203–214 (2010).",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "4a8cdc29-050f-4cea-81cf-628b68d5697a",
      "evidence": "Uses a citation to support a specific failure rate statistic.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 5,
      "beatId": "f7a3673e-4709-4685-ab0b-d60572ad0c16",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Problem Statement",
      "beatSlug": null,
      "evidence": "Slides 5-7 highlight the problems with biologic drug discovery",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "47614036-69cd-478a-9610-1e23cebf963c",
      "evidence": "Slides 5-7 emphasize the failures of biologic drug discovery",
      "position": 0,
      "objective": "Highlight the cost of inaction in biologic drug discovery",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}